Australia Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Start taking a college level music theory class today. This beginner class is now accessible to aspiring musicians of all ages. Learn all of the basic concepts in an easy to follow manner. From our sponsors

Australia Pharmaceuticals and Healthcare Report Q4 2013 Aug 14th 2013, 00:00, by rnrmahesh BMI View: Medicine price reductions and a slowing economy will continue to place downside pressures on pharmaceutical firms in Australia. Contributing to this, the government is looking to provide the population with affordable and sustainable pharmaceutical subsidies. However, the listing of new drugs, coupled with rising demand for pharmaceuticals due to the ageing population, will continue to provide both generic and innovative drugmakers with opportunities. Headline Expenditure Projections ? Pharmaceuticals: AUD13.25bn (US$13.73bn) in 2012 to AUD13.64bn (US$13.43bn) in 2013; +2.9% in local currency terms and -2.1% in US dollar terms, due to exchange rate fluctuations. Forecast downgraded from Q313 due … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110990. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/australia-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions